US$ 23.26
glp-1 receptor agonists blindness risk Eye doctors warn drugs for diabetes and weight loss may pose rare vision risks, recommending regular checkups A nurse lost her eyesight
Description
The pancreatic beta-cell-specific transcription factor Pax-4 inhibits glucagon gene expression through Pax-6
However, plasma concentrations of semaglutide at steady state are estimated to be about 100 times lower than the IC 50 values for OATP1B1/3 (3.50 M and 2.95 M, respectively).56 Moreover, when BSA was added, the inhibitory effect disappeared or was diminished, probably due to the binding of the fatty acid residues of GLP-1 RAs and a dual GLP-1/GIP RA to BSA.70 Table 3

Medications like Wegovy (semaglutide) and Mounjaro (tirzepatide, which is a dual GLP-1/GIP agonist) are administered just once a week using a small, pre-filled injection pen
Others are looking for non-prescription options to support their weight loss journey

Dan Med J

Morel, Genve (Chirurgie)
